The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Rx/reimbursement adult incontinence continued to perform well in 2019, with volume and current value growth rates improving slightly from 2018. As was the case with retail adult incontinence, the positive development of the category was primarily due to population ageing in the Czech Republic.
Incontinence products are considered medical devices under Czech law, and are subsidised by health insurance companies if prescribed by doctors (GPs, urologists, gynaecologists, geriatricians etc). There are monthly limits on the quantity and value of incontinence products for which individual users can be reimbursed.
The same multinational companies that controlled the retail category continued to dominate Rx/reimbursement adult incontinence in 2019. Essity was the leading player with its Tena brand, while other top competitors included Hartmann-Rico with MoliCare, Kimberly-Clark with Depend, Ontex with iD Expert, Untraco with Abri and TZMO with Bella Control.
RX/reimbursement adult incontinence value sales at constant 2019 prices are expected to grow by 1% in 2020 in light of the impact of COVID-19.
RX/reimbursement adult incontinence looks set to perform well over the forecast period, with volume and current value growth rates expected to improve steadily towards 2024. The expansion of the category will continue to be underpinned by population ageing in the Czech Republic.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Czech Republic with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Czech Republic, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Czech Republic market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.